Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update
- MeSH Terms
- Antineoplastic Agents (D27.505.954.248); Neoplasms (C04); Breast Neoplasms (C04.588.180)
- Guideline Contact
- guidelines@asco.org
- Publication Date
- 03-Sep-19
- Publication Scope
- prevention
- Countries of Application
- United States
- Guideline Publication Status
- Published
- Languages
- English
- Authors
- ASCO (US)
- Publication Year
- 2019